Most Read News

Ducon Infratechnologies will hold a meeting of the Board of Directors of the Company on 22 March 2022

Strides Pharma Science announced that an Extra Ordinary General Meeting EGM of the Company will be held on 7 April 2022

Tasty Dairy Specialities announced that Ashok Kumar Tripathi DIN No08363248 has resigned from the board of the company on 12 March 2022

Infosys on 10 March 2022 has allotted 805891 equity shares pursuant to the exercise of Restricted Stock Units by eligible employees as hereunder 494632 equity shares under the 2015 Stock Incentive Compensation Plan; 310449 equity shares under the Infosys Expanded Stock Ownership Program 2019

The Board of Sobha at its meeting held on 14 March 2022 has approved the resignation of Jagdish Chandra Sharma as Director and Vice Chairman and-Managing Director with effect from 01 April 2022 The Board also approved the appointment of Jagadish Nangineni as an Additional Director in the capacity of Whole-time Director designated as Managing Director and Key Managerial Personnel of the Company for a […]

Transport Corporation of India has allotted 41925 Forty One Thousand Nine Hundred Twenty Five Equity Shares under ESOP-2017-3rd Tranche on 15th March 2022

ISMT announced that the company has remitted the full and final settlement amount towards the outstanding debt of the Company to the respective Lenders Authorized Dealers

Hexa Tradex will hold a meeting of the Board of Directors of the Company on 21 March 2022

Mishra Dhatu Nigam announced that the Board of Directors of the Company at its meeting held on 14 March 2022 inter alia have recommended the interim dividend of Rs 156 per equity Share ie 156Percentage subject to the approval of the shareholders

Alembic Pharmaceuticals today announced that it has received tentative approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Macitentan Tablets 10 mg The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product RLD Opsumit Tablets 10 mg of Actelion Pharmaceuticals US Inc Actelion Macitentan Tablets are an endothelin receptor antagonist ERA indicated for the treatment […]